bio.logis GIMS - Home of the Clinical Interpretome
News
| Article
Sars-CoV-2 pandemic: importance of pharmacogenetics for therapy of mental and psychiatric disorders
Doctors point to an increase in psychological health problems and psychiatric illnesses such as depression and anxiety related to the Sars-CoV-2 pandemic. Initial studies document this development, which experts believe may further intensify after the pandemic has subsided.
Events
| Conference
Meet bio.logis at DELAB and 5th German PharmTox Summit
bio.logis will take part in both meetings and our team looks forward to exchanging ideas with you. At the 5th German PharmTox summit we will have a presentation on GIMS.pharma as part of the "Meet the Company" session.
Testimonials
„We are convinced, that the Diagnostic Report Module of the bio.logis Genetic Information Management Suite will improve the process of creating more valuable results, which we provide to our clients (i.e. physicians). This will help us to build a competition advantage.“
"bio.logis is the ideal partner for us to implement personalized pharmacogenetic diagnostics.
We know the GIM system from the EU project Ubiquitious Pharmacogenomics, in which it has already proven its efficiency."
Participation in EU-Projects within Horizon 2020 program
- Ubiquitous Pharmacogenomics (U-PGx)
- Genetics Clinic of the Future (GCOF)
Partners
